|
KMID : 1161220220650120589
|
|
Clinical and Experimental Pediatrics
2022 Volume.65 No. 12 p.589 ~ p.594
|
|
|
Ability of polymicrobial probiotic and mono-strain probiotic to reduce functional abdominal pain in children: a randomized clinical trial
|
|
Jafari Seyed Sajad
Hashemi Seyed Mojtaba
Sadeghi Bahman
Almasi-Hashiani Amir
|
|
|
Abstract
|
|
|
Background: Chronic abdominal pain is a common problem in childhood.
Purpose: Due to the prevalence of functional abdominal pain (FAP) and the importance of probiotics, this study aimed to compare the ability of 2 probiotics to reduce and improve FAP in children.
Methods: This open-label randomized clinical trial included 116 children aged 5?15 years with FAPP who met the ROME-4 criteria and were referred to the gastrointestinal clinic of Amir-Kabir Hospital in Arak in 2020?2021. The children were randomly allocated to receive polymicrobial probiotic (PMP group) or mono-strain probiotic (MSP group) once daily for 4 weeks. The standard Wong-Baker Faces scale was used to assess symptom severity.
Results: Of the 116 subjects, 62 (53.5%) were boys; the mean participant age was 7.39 years (standard deviation, 3.4 years). A significant intergroup difference (P=0.003) was observed in pain severity; 10.34% of children in the PMP group had no pain, while all patients in the MSP group reported low-degree pain. There was no intergroup difference in mean pain score (P=0.466), but it decreased over time in both groups (P= 0.001).
Conclusion: Although significantly more children were painless in the PMP versus MSP group, no significant intergroup difference in pain score was noted and symptom severity decreased in both groups. A future study with a placebo group is recommended to validate our findings.
|
|
|
KEYWORD
|
|
|
Probiotic, Pediatric, Functional abdominal pain, Child, Pain
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|